ArticleBMC biotechnology2026

Affinity enhancement of an anti-VEGF humanized nanobody as a superior candidate to bevacizumab: integrative in silico and in vitro studies.

Mir Salar Kazemi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.